Covid antiviral pill can split risk of Hospitalisation
A drug experiment for severe Covid slashes the risk of hospitalization or death by about half, temporary clinical trial results suggest. The so-called Covid antiviral pill “Molnupirvir” was given twice a day to patients recently identified with the disease. U.S. drugmaker Merck said the result of this drug were so progressive that outside monitors had … Read More